NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
NRx Pharmaceuticals closed a public offering of common stock, raising gross proceeds of approximately $22.3 million. The shares were sold at a price of $3.50 per share, including the exercise of the underwriters' option to purchase additional shares. BTIG acted as lead bookrunner and Lucid Capital Markets as joint bookrunner.
Key figures
- Deal Value Usd
- 22300000
- Offering Price
- 3.5
- Par value
- 0.001
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.